Brief: Nxera Files Patent Infringement Action In Relation To Its Minig Platform Technology
08/05/2026 11:37
May 8 (Reuters) - Nxera Pharma Co Ltd 4565.T: NXERA FILES PATENT INFRINGEMENT ACTION IN RELATION TO ITS MINIG PLATFORM TECHNOLOGY NXERA PHARMA CO LTD - PROCEEDINGS COMMENCED IN PATENTS COURT OF HIGH COURT OF JUSTICE OF ENGLAND AND WALES NXERA PHARMA CO LTD - SEEKS COMPENSATION AND INJUNCTIVE RELIEF IN PATENT CASE NXERA PHARMA CO LTD - UNIT FILES PATENT INFRINGEMENT SUIT AGAINST OMASS THERAPEUTICS OVER MINIG TECHNOLOGY Source text: ID:nGNXJtmnD Further company coverage: 4565.T ((((Reuters.Briefs@thomsonreuters.com;));))
Recent news on Nxera Pharma
See all newsNxera Pharma Submits Marketing Authorization Application For Vamorolone In South Korea For Treatment Of Duchenne Muscular Dystrophy
Factbox: Weight-loss drug developers line up to tap lucrative market as competition heats up
Brief: Nxera Pharma - Entered Into Exclusive License, Supply And Commercialization Agreement With Synmosa For Quviviq Across Eight Asia-Pacific Markets
Brief: Nxera Announces Successful Resolution Of Minig Patent Infringement Action
Factbox: Weight-loss drug developers line up to tap lucrative market as competition heats up